Loomis, Sayles & Company
SCLN

Loomis, Sayles & Company’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Loomis, Sayles & Company’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-828
Closed -$8K – 1161
2016
Q3 		$8K Buy
828
+408
+97% +$3.94K ﹤0.01% 813
2016
Q2 		$5K Buy
+420
New +$5K ﹤0.01% 865